Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency.
Methionine synthase (MS) catalyses the methylation of homocysteine to methionine and requires the vitamin B12 derivative, methylcobalamin, as cofactor. We and others have recently cloned cDNAs for MS and described mutations associated with the cblG complementation group that correspond to MS deficiency. A subset of cblG, known as "cblG variant," shows no detectable MS activity and failure of [57Co]CN cobalamin to incorporate into MS in patient fibroblasts. We report the mutations responsible for three cblG-variant patients, two of them siblings, who presented with neonatal seizures, severe developmental delay, and elevated plasma homocysteine. Cell lines from all three patients were negative by northern blotting, though trace MS mRNA could be detected by means of phosphorimage analysis. Reverse transcriptase-PCR, SSCP, and nucleotide sequence analysis revealed four mutations. All were functionally null, creating either a frameshift with a downstream stop codon or an insert containing an internal stop codon. Of the two mutations found in the siblings, one of them, intervening sequence (IVS)-166A-->G, generates a cryptic donor splice site at position -166 of an intron beginning after Leu113, resulting in a 165-bp insertion of intronic sequence at junction 339/340. The second is a 2-bp deletion, 2112delTC. Mutations in the third patient include a G-->A substitution, well within the intron after Lys203, which results in intronic inserts of 128 or 78 bp in the mRNA. The second mutation is a 1-bp insertion, 3378insA. We conclude that the absence of MS protein in these cblG variants is due to mutations causing premature translation termination and consequent mRNA instability.
Medical Research Council Group in Medical Genetics, Montreal Children's Hospital,Canada.
A
A
Wilson
D
D
Leclerc
F
F
Saberi
E
E
Campeau
H Y
HY
Hwang
B
B
Shane
J A
JA
Phillips
D S
DS
Rosenblatt
R A
RA
Gravel
D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / Q000172:deficiency* / Q000235:genetics* / Q000378:metabolism; D002460:Cell Line; D002648:Child; D003001:Cloning, Molecular; D018388:Codon, Terminator; D018076:DNA, Complementary; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D016368:Frameshift Mutation; D005816:Genetic Complementation Test; D014644:Genetic Variation; D006710:Homocysteine / Q000378:metabolism; D006712:Homocystinuria / Q000201:enzymology / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D007438:Introns; D008297:Male; D008715:Methionine / Q000097:blood; D009679:Nuclear Family; D018807:Polymorphism, Single-Stranded Conformational; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012867:Skin / Q000201:enzymology; D014158:Transcription, Genetic; D014805:Vitamin B 12 / Q000031:analogs & derivatives / Q000378:metabolism
D018388:Codon, Terminator; D018076:DNA, Complementary; D012333:RNA, Messenger; D006710:Homocysteine; D008715:Methionine; C019476:mecobalamin; D013766:5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; D014805:Vitamin B 12